h1

h2

h3

h4

h5
h6

001     812748
005     20260323123002.0
024 7 _ |2 HSB
|a eva31935
024 7 _ |2 ISSN
|a 2297-055X
024 7 _ |2 SCOPUS
|a SCOPUS:2-s2.0-85100795120
024 7 _ |2 WOS
|a WOS:000598479400001
024 7 _ |2 doi
|a 10.3389/fcvm.2020.610344
024 7 _ |2 pmid
|a pmid:33335915
037 _ _ |a RWTH-CONV-243709
041 _ _ |a English
100 1 _ |a Babendreyer, Aaron
|b 0
|e Corresponding author
|u rwth
245 _ _ |a Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells
|h online
260 _ _ |a Lausanne
|b Frontiers Media
|c 2020
336 7 _ |0 0
|2 EndNote
|a Journal Article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
536 _ _ |0 G:(DE-82)EXS-PF-PFLS011
|a PFLS011 - Ultrathin nanofiber as basement membrane mimic for maintenance of a non-inflammatory endothelial phe-notype (EXS-PF-PFLS011)
|c EXS-PF-PFLS011
|x 0
536 _ _ |0 G:(DE-82)EXS-PF
|a ERS Prep Fund - Exploratory Research Space: Prep Fund als Anschubfinanzierung zur Schließung strategischer Lücken (EXS-PF)
|c EXS-PF
|x 1
536 _ _ |0 G:(DE-82)EXS
|a EXS - Excellence Strategy (EXS)
|c EXS
|x 2
591 _ _ |a Germany
700 1 _ |a Rojas-González, Diana M.
|b 1
700 1 _ |a Giese, Anja Adelina
|b 2
|u rwth
700 1 _ |a Fellendorf, Sandra
|b 3
|u rwth
700 1 _ |a Düsterhöft, Stefan
|b 4
700 1 _ |a Mela, Petra
|b 5
700 1 _ |a Ludwig, Andreas
|b 6
|u rwth
773 _ _ |0 PERI:(DE-600)2781496-8
|a 10.3389/fcvm.2020.610344
|p 610344
|t Frontiers in Cardiovascular Medicine
|v 7
|x 2297-055X
914 1 _ |y 2020
915 1 _ |0 StatID:(DE-HGF)0031
|2 StatID
|a Peer reviewed article
|x 0
915 _ _ |0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|a Creative Commons Attribution CC BY (No Version)
|b DOAJ
|d 2021-05-13T10:28:25Z
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b DOAJ : Blind peer review
|d 2021-05-13T10:28:25Z
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b FRONT CARDIOVASC MED : 2021
|d 2022-11-16
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2022-11-16
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2022-11-16
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2022-11-16
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2022-11-16
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2022-11-16
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2022-11-16
915 _ _ |0 StatID:(DE-HGF)0500
|2 StatID
|a DBCoverage
|b DOAJ
|d 2021-05-13T10:28:25Z
915 _ _ |0 StatID:(DE-HGF)0501
|2 StatID
|a DBCoverage
|b DOAJ Seal
|d 2021-05-13T10:28:25Z
915 _ _ |0 StatID:(DE-HGF)0561
|2 StatID
|a Article Processing Charges
|d 2022-11-16
915 _ _ |0 StatID:(DE-HGF)0700
|2 StatID
|a Fees
|d 2022-11-16
915 _ _ |0 StatID:(DE-HGF)1110
|2 StatID
|a DBCoverage
|b Current Contents - Clinical Medicine
|d 2022-11-16
915 _ _ |0 StatID:(DE-HGF)9905
|2 StatID
|a IF >= 5
|b FRONT CARDIOVASC MED : 2021
|d 2022-11-16
920 1 _ |0 I:(DE-82)528500-3_20140620
|k 528500-3
|l Institut und Lehrstuhl für Klinische Pharmakologie
|x 0
920 1 _ |0 I:(DE-82)9775200_20140620
|k 9775200
|l Institut für Pharmakologie und Toxikologie
|x 1
970 _ _ |a eva31935
980 _ _ |a I:(DE-82)528500-3_20140620
980 _ _ |a I:(DE-82)9775200_20140620
980 _ _ |a IMPORT
980 _ _ |a UNRESTRICTED
980 _ _ |a VDBINPRINT
980 _ _ |a journal

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21